Implementing Green Chemistry In Biopharma: Design To Delivery

By Girish Basavaraju, Ph.D., Process Engineering, Risk Management and Technical Services, and Manasa Jayavibhava, Team Lead, Process Engineering

The UN Climate Change Conference in Glasgow 2021 (COP26) highlighted the responsibility of individuals and companies in tackling the challenges of protecting our planet. With the biopharma industry being a significant contributor to environmental pollution, there is an urgent need to adopt Green Chemistry at all stages of drug development – design to delivery.

Green Chemistry refers to technology, products, and processes that can minimize or eliminate the use or generation of hazardous substances during the design, development, and manufacture of chemical products. Green metric tools and technologies can positively impact the environment, people, and business growth. Further, applying a Green strategy in drug development can reduce the number of synthetic conversions, shorten the linear synthetic route, and maximize the atom economy.

In this point of view, we discuss how Syngene supports clients in developing pathbreaking therapies while ensuring minimal environmental impact in keeping with its Green Chemistry approach.